Dr. Drew trashes chronic pain patients as “borderline druggies”

Last week on his podcast This Life You Live, celebrity addiction specialist Dr. Drew Pinsky called chronic pain patients “borderline druggies” for seeking medical treatment in the form of pain medication. Not surprisingly, this angered thousands of chronic pain patients who are now struggling to receive proper treatment from their doctors in the aftermath of …

Dr. Drew trashes chronic pain patients as “borderline druggies” Read More »

Philadelphia Inquirer’s continuing attacks on the kratom community

In the last year Philadelphia Inquirer reporter Mari A. Schaefer has written several articles with headlines like “Deaths from kratom, sold as an herbal supplement, are rising”. Her colleague Scott Sturgis, an editor at the Inquirer, is suing a kratom vendor after his son Caleb died in a car accident. The Chester County, Pa coroner …

Philadelphia Inquirer’s continuing attacks on the kratom community Read More »

Interview with Dirk Netter, author of the first German language book about kratom

Dirk Netter is the author of the first major German language book on kratom. Kratom – Ethnobotanik, Anwendung, Kultur (English: Kratom – Ethnobotany, Application, and Culture) is soon to be released by Nachtschatten Verlag (Nightshade Press), a publisher from Switzerland. In 2018, Netter founded HIPF, or Hochschulgruppe für interdisziplinäre psychedelische Forschung, translated to English: the …

Interview with Dirk Netter, author of the first German language book about kratom Read More »

PA House resolution seeking regulatory guidance from the FDA contains language explaining why it shouldn’t

A proposed resolution introduced to the Pennsylvania House on Tuesday, September 3rd would officially request guidelines for kratom regulation in the state from none other than the FDA. HR460’s primary sponsor is Rep. Jim Struzzi. It is co-sponsored by other representatives from rural PA counties (contact info below). Many kratom consumers have been commenting on …

PA House resolution seeking regulatory guidance from the FDA contains language explaining why it shouldn’t Read More »